Exploratory Pathology in Action: Advancing Nonclinical Drug Development Across Therapeutic Areas

Exploratory pathology leverages the knowledge and expertise of comparative medicine, pathological processes and biomedical research activities to understand mechanisms of disease and disease pathogenesis and help guide the evaluation and potential impact of treatments on health and disease progression.

This webinar will provide a comprehensive overview of how exploratory pathology can provide the scientific expertise across multiple phases of drug development. Examples of how exploratory pathology contributes to early discovery, lead optimization and exploration of pathogenic mechanisms and how to address challenges across multiple therapeutic modalities will be discussed.

Attendees will also learn the importance and value of incorporating exploratory pathology components in their nonclinical drug development programs across multiple therapeutic areas, including neuropathology, immunopathology, ocular pathology and medical devices.

Register for this webinar today to learn how exploratory pathology can provide key pathologic data advance nonclinical drug development programs across discovery and safety assessment.

Keywords: Drug Development, Drug Discovery, Clinical Research, Pathology, Therapeutic Areas, Digital Pathology, Diagnostic Pathology, Pre-Clinical, Exploratory Pathology, Discovery Pathology, Nonclinical

Others Details

Life Sciences,Pharma,Drug Discovery & Development